Shenghong Ju

64PUBLICATIONS
316CO-AUTHORS
Molecular targetsCancer diagnosisMedical devicesPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Jul 21, 2026
ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer.

|May 04, 2026
Reply to the Letter to the Editor: Enhancing Node-RADS for preoperative assessment of cervical lymph node metastases in papillary thyroid carcinoma: a focused question on patient-level decision-making.

|Mar 18, 2026
Programmable nanomicelles rewire myeloid immunity for durable control of primary and metastatic breast cancer.

Jie Yang, Di Chang, Yingbo Li

|Feb 26, 2026
Enhancing Node-RADS for preoperative assessment of cervical lymph node metastases in papillary thyroid carcinoma: validation and modification.

Yanjun Wang, Jinlu Hou, Xunjun Chen

|Jan 21, 2026
In situ self-assembled cell reservoir hydrogel for maneuvering multistage radioimmunotherapy.

Yue Chen, Qinyi Chen, Yuanyuan Ma

|Dec 29, 2025
Genetic Dissection of Plasma Proteins and Blood Pressure in Small Vessel Disease.

Yaoyao Yu, Tianyi Xia, Yinlu Wang

Pageof 11

Frequent Collaborators

6 joint publications

Wenpei Fan

4 joint publications

Tianyu Tang

4 joint publications

Zebin Xiao

4 joint publications

Tianyi Xia